"Money raised at a premium which is good but it does seem to suggest that they are going to self-fund the trials on their own."
Clearly they wanted the cash for a reason. That would be the most likely one. I am guessing they couldn't get a favourable deal from big pharma, so they think this is a better way.
Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-17
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)